189 related articles for article (PubMed ID: 19167496)
1. 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer.
Jansson A
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):64-7. PubMed ID: 19167496
[TBL] [Abstract][Full Text] [Related]
2. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
3. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer.
Oduwole OO; Li Y; Isomaa VV; Mäntyniemi A; Pulkka AE; Soini Y; Vihko PT
Cancer Res; 2004 Oct; 64(20):7604-9. PubMed ID: 15492288
[TBL] [Abstract][Full Text] [Related]
4. Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
Jansson A; Delander L; Gunnarsson C; Fornander T; Skoog L; Nordenskjöld B; Stål O
Clin Cancer Res; 2009 May; 15(10):3610-6. PubMed ID: 19401349
[TBL] [Abstract][Full Text] [Related]
5. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
7. Expression of COX-2 and steroid converting enzymes in breast cancer.
Gunnarsson C; Jansson A; Holmlund B; Ferraud L; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Oncol Rep; 2006 Aug; 16(2):219-24. PubMed ID: 16820896
[TBL] [Abstract][Full Text] [Related]
8. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
9. Enzymes as modulators in malignant transformation.
Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
[TBL] [Abstract][Full Text] [Related]
10. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
11. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2.
Vihko P; Isomaa V; Ghosh D
Mol Cell Endocrinol; 2001 Jan; 171(1-2):71-6. PubMed ID: 11165013
[TBL] [Abstract][Full Text] [Related]
13. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
14. 17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.
Gunnarsson C; Hellqvist E; Stål O
Br J Cancer; 2005 Feb; 92(3):547-52. PubMed ID: 15685233
[TBL] [Abstract][Full Text] [Related]
15. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
Miki Y; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):68-71. PubMed ID: 19444935
[TBL] [Abstract][Full Text] [Related]
16. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors and estrogen-metabolizing enzymes in human ovaries during fetal development.
Vaskivuo TE; Mäentausta M; Törn S; Oduwole O; Lönnberg A; Herva R; Isomaa V; Tapanainen JS
J Clin Endocrinol Metab; 2005 Jun; 90(6):3752-6. PubMed ID: 15784714
[TBL] [Abstract][Full Text] [Related]
18. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
19. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
20. Estrogen metabolism as a regulator of estrogen action in the mammary gland.
Miettinen M; Isomaa V; Peltoketo H; Ghosh D; Vihko P
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):259-70. PubMed ID: 14973388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
